Industry Experts

Anandaroop Mukhopadhyay is the Senior Director of In Vivo Pharmacology at Arda Therapeutics, spearheading preclinical development and translational strategy for targeted biologics. As a veteran pharmacologist, he has navigated complex large-molecule drug discovery from conceptualization through IND-enabling packages and early clinical development.

His career includes pivotal roles, including senior leadership positions where he drove large-molecule biologics programs at OncoSec, Bristol Myers Squibb, and Pfizer. His deep domain expertise in cellular targeting, tissue-level distribution, and in vivo mechanisms of action is grounded in rigorous academic training, including a PhD specializing in Fibrosis from the National University of Singapore, a postdoctoral fellowship at UCSD, and tenure as a Research Scientist at the Huntsman Cancer Institute. With a holistic bench-to-clinic perspective, Anand is uniquely suited to moderate discussions on the design, safety, and therapeutic boundaries of next-generation T-cell engagers.